@todotvnews - 29/05/2015
0
printer


Whats New in LatAm this Week?

Canal 13 brings back drama unit, Netflix and Univision present Tijuana, Univision opens its doors to Turkish dramas, Cobra Kai among Argentina's most demanded, Two Armoza dramas reach Brazil, and more. 



CHILE

Canal 13 brings drama unit back thanks to Prodco AGTV. After dismantling its fiction unit and amidst a strong restructure process, the Chilean network will outsource the production of television series, thus signing a deal with Pablo Ávila's production company, which up until now, had strong ties to Mega. The new alliance with AGTV establishes the production of at least 10 fiction products for the primetime 8pm to 10:30pm timeslots.

US HISPANIC

New coproduction between Netflix and Univision takes shape. According to Deadline, Damián Alcázar (Narcos) and Tamara Vallarta (Paquita la del Barrio) will spearhead the cast of Tijuana, the much anticipated premium drama from both companies. The show is expected to premiere this year in the US on Univision, and then have its international release on Netflix.

US HISPANIC

Univision opens its doors to Turkish dramas. Turkish distributor Inter Medya has announced a deal with Univision, which acquired dramas Mrs. Fazilet and her Daughters, Red Scarf and In Between for broadcast in the US. "All three of these series are perfect examples of the success of Turkish drama series across the globe," said Can Okan, Founder and CEO of Inter Medya.

ARGENTINA

Cobra Kai among Argentina's most demanded content. YouTube Premium made its way into the list of most demanded original series in Argentina, according to Parrot Analytics, following 13 Reasons Why, which led the list. The series tallied 2,373,525 Average Demand Expressions.

BRAZIL

Two Armoza dramas reach Brazil through Globo. The Israeli distributor has sold its two hit dramas, Eclipse and Refuge, to the Brazilian broadcaster, to air on its GNT channel this year. Armoza Formats is distributing the series both as finished tapes and as formats.


comments powered by Disqus Link